论文部分内容阅读
目的:输血救治非霍奇金淋巴瘤急性溶血性贫血危象患者,卡式微柱抗人球法配血输血无效时采用体外溶血试验配血为非霍奇金淋巴瘤急性溶血性贫血危象患者筛查相容血液。方法:卡式微柱抗人球法配血困难,采用体外溶血试验配血,筛选卡式微柱抗人球配血结果凝集但补体试验不溶血红细胞11.5单位再次输注。结果:体外溶血试验配血法共筛查36袋血液,为患者筛查6袋(共11.5单位)凝集-不溶血去白细胞红细胞悬液。结论:患者输注11.5单位凝集不溶血去白细胞后临床表现输血安全、有效,无不良反应,输血后血红蛋白上升快,结果稳定。
OBJECTIVE: Blood transfusions were used to treat acute hemolytic anemia crisis in non-Hodgkin’s lymphoma patients. Hepatocellular carcinoma Screen for compatible blood. Methods: It was difficult to dispense blood with card-type micro-column anti-human sphere method. Blood was collected by in vitro hemolysis assay and clotted with card-type micro-column anti-human sphere. However, 11.5 units of insoluble hemoglobin was infused again by complement assay. RESULTS: In vitro hemolysis test was performed on 36 bags of blood with hemolytic method. Six patients (11.5 units) were aggregated and hemolysised to remove leukocyte erythrocyte suspension. CONCLUSION: The transfusion of 11.5 units of coagulated and insoluble hemagglutinated leukocytes was safe, effective and no adverse reactions. The hemoglobin after transfusion increased rapidly and the result was stable.